Could genetic testing for prostate cancer transform routine care? a study asks patients and doctors
NCT ID NCT07741929
First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time
Summary
This study explores how patients and healthcare providers view the use of genetic risk profiling for prostate cancer in everyday clinical practice. Through interviews, researchers aim to understand the benefits, challenges, and needs associated with receiving and delivering genetic risk results. The findings may help guide how such testing could be better integrated into routine care, ensuring it is practical and supportive for all involved.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Qualitative interviews
- What this could lead to
- If successful, this study could help shape how genetic risk profiling for prostate cancer is integrated into routine clinical care, improving patient education, support, and clinical guidelines.
- What could go wrong
- This is a small, interview-based study, so its findings may not represent all perspectives. It does not test a treatment or intervention, so it cannot directly change patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Royal Marsden Hospital (Sutton and Chelsea)
RECRUITINGLondon, SM2 5PT, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks
- Can an immune booster make hormone therapy work better against prostate cancer?